Skip to content

Steps for Epilepsy

A Feasibility Study of a Step-goal Based Physical Activity Intervention in People With Epilepsy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05359003
Acronym
StEpi
Enrollment
26
Registered
2022-05-03
Start date
2023-02-13
Completion date
2024-10-01
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

physical activity, step goal, tele health

Brief summary

The purpose of this research study is to evaluate the feasibility of a 12-week, telehealth delivered, step-goal based physical activity intervention in people with epilepsy. The study team will also evaluate the physical activity profiles of people with epilepsy both at rest and when engaged in physical activity and gather information on the effect of the intervention on epilepsy and epilepsy associated comorbidities.

Detailed description

This is a randomized, controlled, pilot trial to assess the feasibility of a 12-week telehealth delivered, step-goal based physical activity intervention in people with epilepsy. This will be carried out using a 2-arm, parallel group design with a healthy living education control. Participants will undergo formal exercise testing to establish a baseline fitness level and safety of participation. They will wear Garmin activity tracker on their wrist throughout the study to track their steps. During a 4 week baseline period, we will gather data on baseline physical activity levels and seizure frequency. Participants will then be randomized to either the intervention group or a healthy living education control group. The intervention group will undergo a 12-week, telehealth delivered, step goal based physical activity intervention with a goal of ultimately achieving at least 8,000 steps per day. The intervention will utilize social cognitive theory to encourage lasting behavior changes and have weekly group coaching sessions with a trained health and behavior change provider. The control group will receive education every two weeks but will not be given a coaching plan. The study will evaluate adherence to the intervention, sustainability of the intervention over 12 weeks after the formal coaching program ends, and acceptability of the intervention. The study will also investigate the physical activity profile of people with epilepsy both at rest and when asked to participate in physical activity with a self-selected intensity and bout duration. The study will collect information on the effect of the intervention on seizures, mood, quality of life, sleep, fitness, and heart-rate variability, as well as other epilepsy relevant outcomes.

Interventions

BEHAVIORAL12-week Physical Activity Program

Participants in this arm will undergo a 12-week physical activity program aimed to achieve the equivalent of 8,000 steps per day (56,000 weekly steps). Includes weekly meetings with a trained health coach.

Sponsors

National Center for Advancing Translational Sciences (NCATS)
CollaboratorNIH
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

A randomized, controlled trial with a two-arm, parallel group design with a healthy living education control

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Focal or generalized epilepsy, as determined clinically by a WFBH epileptologist with no significant consideration of an alternative diagnosis * Access to a smartphone with application capabilities * Internet access or cellular data plan to attend virtual sessions * Able to ambulate independently

Exclusion criteria

* Diagnosis of nonepileptic or psychogenic spells * Seizures associated with falls with injury (such as atonic seizures) * Medical conditions that would limit ability to participate in an exercise intervention including: Stage III or IV Congestive Heart Failure (CHF); End-stage Renal Disease; Severe dementia or significant cognitive impairment that precludes participation in the intervention or limits ability to follow the study protocol; Uncontrolled hypertension (HTN) defined as systolic blood pressure greater than 180 mmHg and diastolic blood pressure greater than 110 mmHg at rest; Severe arthritis, amputations, or orthopedic problems that limit ambulatory ability * Currently pregnant or plan to become pregnant during the study period (16 weeks) * An active Central Nervous System (CNS) infection, demyelinating disease, degenerative neurologic disease or any CNS disease deemed to be progressive during the course of the study that may confound the interpretation of the study results * Any clinically significant psychiatric illness, psychological, or behavioral problems that would interfere with the subject's ability to participate in the study. * Unwilling or unable to comply with all study visits and procedures * Participants who have \<75% complete days of seizure recording in the study diary or step data via the Garmin device will not be randomized.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Participants Who Achieve Their Assigned Step Goal - AdherenceWeek 12 to Week 16As measured by average daily steps via the Garmin device over the last 4 weeks of the intervention period.
Proportion of Participants Who Achieve Their Assigned Step Goal - SustainabilityWeek 24 to Week 28As measured by average daily steps via the Garmin device over the last 4 weeks of the maintenance period, will be calculated and 95% binomial confidence intervals generated.

Secondary

MeasureTime frameDescription
Time Spent in Moderate Intensity ActivityWeek 4Time spent in moderate intensity in the last week of baseline as measured by the Garmin watch.
Time Spent in Vigorous Intensity ActivityWeek 4Time spent in vigorous intensity in the last week of baseline as measured by the Garmin watch.
Time Spent SedentaryWeek 4Time spent sedentary during the last week of baseline as measured by the Garmin watch.
Exercise Satisfaction Survey- Proportion of Participants With a 4 or Higher ResponseWeek 16We will use the question How satisfied were you with the exercise intervention? with scale of 1-5, 1=VERY UNSATISFIED, 2=UNSATISFIED, 3=NEUTRAL, 4=SATISFIED, 5=VERY SATISFIED. Higher numbers denotes better outcomes. We will calculate the proportion of subjects who answer 4 or above.
Exit SurveyWeek 28The scale ranges from 4-20 with higher scores indicating greater satisfaction with the study.
Time Spent in Light Intensity ActivityWeek 4Time spent in light intensity in the last week of baseline as measured by the Garmin watch.

Countries

United States

Participant flow

Pre-assignment details

During a 4-week baseline period, the participants will continue their usual activity but will wear the Garmin and ActivPAL 4 and keep a study diary. We will use this to assess their baseline PA profiles and seizure frequency and to screen for adherence with device and diary use, as participants who have \<75% complete days of seizure recording or step data via the Garmin will not be randomized.

Participants by arm

ArmCount
Arm 1: Physical Activity Intervention
Participants in this arm will undergo a 12-week physical activity program aimed to achieve the equivalent of 8,000 steps per day (56,000 weekly steps). Includes weekly meetings with a trained health coach.
15
Arm 2: Control
Participants randomized to the healthy living education control group will continue to undergo standard care for 12 weeks with a phone call from the coach every 2 weeks on topics of healthy living (topics include: keeping a seizure diary, sleep, medication adherence, stress, diet, emotional health)
6
Total21

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject13

Baseline characteristics

CharacteristicArm 2: ControlTotalArm 1: Physical Activity Intervention
Age, Continuous33.7 years
STANDARD_DEVIATION 7.66
36.41 years
STANDARD_DEVIATION 10.89
37.5 years
STANDARD_DEVIATION 12
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants21 Participants15 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants3 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
White
5 Participants17 Participants12 Participants
Sex: Female, Male
Female
3 Participants13 Participants10 Participants
Sex: Female, Male
Male
3 Participants8 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 6
other
Total, other adverse events
11 / 154 / 6
serious
Total, serious adverse events
4 / 151 / 6

Outcome results

Primary

Proportion of Participants Who Achieve Their Assigned Step Goal - Adherence

As measured by average daily steps via the Garmin device over the last 4 weeks of the intervention period.

Time frame: Week 12 to Week 16

Population: Pre-specified to collect data and report results for Arm 1: Physical Activity Intervention only.

ArmMeasureValue (NUMBER)
Arm 1: Physical Activity InterventionProportion of Participants Who Achieve Their Assigned Step Goal - Adherence0.267 Proportion
Primary

Proportion of Participants Who Achieve Their Assigned Step Goal - Sustainability

As measured by average daily steps via the Garmin device over the last 4 weeks of the maintenance period, will be calculated and 95% binomial confidence intervals generated.

Time frame: Week 24 to Week 28

Population: Pre-specified to collect data and report results for Arm 1: Physical Activity Intervention only.

ArmMeasureValue (NUMBER)
Arm 1: Physical Activity InterventionProportion of Participants Who Achieve Their Assigned Step Goal - Sustainability0.143 Proportion
Secondary

Exercise Satisfaction Survey- Proportion of Participants With a 4 or Higher Response

We will use the question How satisfied were you with the exercise intervention? with scale of 1-5, 1=VERY UNSATISFIED, 2=UNSATISFIED, 3=NEUTRAL, 4=SATISFIED, 5=VERY SATISFIED. Higher numbers denotes better outcomes. We will calculate the proportion of subjects who answer 4 or above.

Time frame: Week 16

Population: Pre-specified to collect data and report results for Arm 1: Physical Activity Intervention only. Only 13 participants were analyzed because 1 participant dropped out and 1 participant did not complete the survey.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Arm 1: Physical Activity InterventionExercise Satisfaction Survey- Proportion of Participants With a 4 or Higher Response9 Participants
Secondary

Exit Survey

The scale ranges from 4-20 with higher scores indicating greater satisfaction with the study.

Time frame: Week 28

Population: For the Control Group: 3 dropouts participants did not complete the survey, and 1 participant only partially completed this form. Only 2 were analyzed.

ArmMeasureValue (MEAN)Dispersion
Arm 1: Physical Activity InterventionExit Survey18.43 score on a scaleStandard Deviation 1.95
Arm 2: ControlExit Survey17.50 score on a scaleStandard Deviation 2.12
Secondary

Time Spent in Light Intensity Activity

Time spent in light intensity in the last week of intervention as measured by the Garmin watch.

Time frame: Week 16

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Light Intensity Activity374 avg minutes per week in light intensity
Arm 2: ControlTime Spent in Light Intensity Activity355 avg minutes per week in light intensity
Secondary

Time Spent in Light Intensity Activity

Time spent in light intensity in the last week of maintenance as measured by the Garmin watch.

Time frame: Week 28

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Light Intensity Activity305 avg minutes per week in light intensity
Arm 2: ControlTime Spent in Light Intensity Activity742 avg minutes per week in light intensity
Secondary

Time Spent in Light Intensity Activity

Time spent in light intensity in the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Light Intensity Activity364 avg minutes per week in light intensity
Arm 2: ControlTime Spent in Light Intensity Activity297 avg minutes per week in light intensity
Secondary

Time Spent in Moderate Intensity Activity

Time spent in moderate intensity in the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Moderate Intensity Activity99.6 avg minutes per week in moderate
Arm 2: ControlTime Spent in Moderate Intensity Activity45 avg minutes per week in moderate
Secondary

Time Spent in Moderate Intensity Activity

Time spent in moderate intensity in the last week of maintenance as measured by the Garmin watch.

Time frame: Week 28

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Moderate Intensity Activity179 avg minutes per week in moderate
Arm 2: ControlTime Spent in Moderate Intensity Activity141 avg minutes per week in moderate
Secondary

Time Spent in Moderate Intensity Activity

Time spent in moderate intensity in the last week of intervention as measured by the Garmin watch.

Time frame: Week 16

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Moderate Intensity Activity175 avg minutes per week in moderate
Arm 2: ControlTime Spent in Moderate Intensity Activity110 avg minutes per week in moderate
Secondary

Time Spent in Vigorous Intensity Activity

Time spent in vigorous intensity in the last week of maintenance as measured by the Garmin watch.

Time frame: Week 28

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Vigorous Intensity Activity57.3 avg minutes per week in vigorous
Arm 2: ControlTime Spent in Vigorous Intensity Activity160 avg minutes per week in vigorous
Secondary

Time Spent in Vigorous Intensity Activity

Time spent in vigorous intensity in the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Vigorous Intensity Activity81.6 avg minutes per week in vigorous
Arm 2: ControlTime Spent in Vigorous Intensity Activity40.8 avg minutes per week in vigorous
Secondary

Time Spent in Vigorous Intensity Activity

Time spent in vigorous intensity in the last week of intervention as measured by the Garmin watch.

Time frame: Week 16

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent in Vigorous Intensity Activity61.7 avg minutes per week in vigorous
Arm 2: ControlTime Spent in Vigorous Intensity Activity156 avg minutes per week in vigorous
Secondary

Time Spent Sedentary

Time spent sedentary during the last week of intervention as measured by the Garmin watch.

Time frame: Week 16

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent Sedentary5608 avg minutes per week spent sedentary
Arm 2: ControlTime Spent Sedentary5344 avg minutes per week spent sedentary
Secondary

Time Spent Sedentary

Time spent sedentary during the last week of baseline as measured by the Garmin watch.

Time frame: Week 4

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent Sedentary4790 avg minutes per week spent sedentary
Arm 2: ControlTime Spent Sedentary3356 avg minutes per week spent sedentary
Secondary

Time Spent Sedentary

Time spent sedentary during the last week of maintenance as measured by the Garmin watch.

Time frame: Week 28

ArmMeasureValue (MEAN)
Arm 1: Physical Activity InterventionTime Spent Sedentary4266 avg minutes per week spent sedentary
Arm 2: ControlTime Spent Sedentary5697 avg minutes per week spent sedentary

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026